Skip to content

13F-HR filed by BOONE CAPITAL MANAGEMENT LLC

BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 13 holding rows worth $296,467,181.

Accession
0001214659-25-002826
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 13 entries on the cover page, a total value of $296,467,181 stated on the cover page (in dollars after the unit check, H1), rows summing to $296,467,181 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNUM GROUP COM91529Y106Stock803,865$58,706,261dollars as filed
GLOBUS MED INC CL A379577208Stock568,465$47,017,740dollars as filed
PERRIGO CO PLC SHSG97822103Stock1,022,369$26,285,107dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM581,843$24,059,208dollars as filed
MOLINA HEALTHCARE INC60855R100COM81,842$23,820,114dollars as filed
Cigna Corporation125523100COM85,861$23,709,657dollars as filed
ORTHOFIX MED INC68752M108COM1,057,313$18,460,685dollars as filed
PENNANT GROUP INC70805E109COM641,255$17,006,083dollars as filed
BIOHAVEN LTDG1110E107COM361,420$13,499,037dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock524,868$13,489,108dollars as filed
IQVIA HLDGS INC COM46266C105Stock57,141$11,228,778dollars as filed
GENWORTH FINL INC37247D106COM SHS1,536,612$10,740,918dollars as filed
VIKING THERAPEUTICS INC92686J106COM209,853$8,444,485dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-25-002826this filing2025-02-14acceptance time not in the bulk data set